The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes
Fergus Caskey, J. Athene Lane(University of Bristol), Yoav Ben‐Shlomo(University of Bristol), Ken Farrington(University of Hertfordshire), Ammar Annaw(University of Bristol), Jenny Donovan(At Bristol), Julia Wade(University of Bristol), Helen Lewis-White(Southmead Hospital), Sunita Procter(University of Bristol), Albert Power(North Bristol NHS Trust), William Hollingworth(At Bristol), David C. Wheeler(University College London), Leila Rooshenas(University Hospitals Bristol NHS Foundation Trust), Jodi Taylor(University of Bristol), Stephanie MacNeill(University of Bristol), Andrew Davenport(The Royal Free Hospital), Karen Alloway(Southmead Hospital), Kristian Law(At Bristol), Yumeng Liu(University of Bristol), Sandip Mitra(Manchester Academic Health Science Centre)
Cited by 39
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes
|Kidney International|2007|1.5k
A Randomized Trial of Vertebroplasty for Osteoporotic Spinal Fractures
|New England Journal of Medicine|2009|1.4k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k